Medical Affairs Strategic Summit East has ended
avatar for Jill Massey, PharmD, MBA, BCMAS

Jill Massey, PharmD, MBA, BCMAS

Melinta Therapeutics
Senior Vice President, Medical Affairs
Dr. Massey has 27 years of medical affairs experience in the commercialization and life-cycle management of pharmaceutical products across multiple therapeutic areas including cardiovascular disease, infectious diseases, neuroscience, pain management, women’s health, psychiatric disorders, and peri-operative care.  She is recognized for her expertise in strategic planning, leadership development, collaborative partnerships, and effective business integrations across multiple business functions. Throughout her career, Jill has focused on creating value-based medical affairs solutions through high performing teams and external alliances.
In her role as senior vice president of medical affairs at Melinta Therapeutics, Inc., Jill is responsible for promoting responsible and sustainable use of Melinta’s antibiotics through data generation and dissemination, developing external strategic alliances with professional organizations and societies, trade associations, and government organizations to promulgate Melinta’s mission and objectives, and demonstrating best in class Medical Affairs performance. She has led the strategic development and outcomes measurement of the Melinta Antimicrobial Resistance Program (AMR) and the Medical Affairs organization as a member of the Senior Management Team.
Prior to joining Melinta, Dr. Massey served as senior vice president of Global Health Science for The Medicines Company where she led the company’s medical initiatives supporting Infectious Diseases, Cardiovascular Diseases, and Surgery and Perioperative Care. Earlier, she held several senior positions at Johnson & Johnson, most recently as vice president of scientific affairs for Janssen Pharmaceutical Companies where she was responsible for all US field-based medical teams, medical information, independent medical education, promotional review, scientific content strategy and digital medical engagement (JanssenMD), US call center, and scientific business merger and acquisitions. It was during her tenure at Janssen that Jill formed a strategic alliance with Drexel University LeBow College of Business to develop an executive MBA program for scientific professionals. Before joining Janssen, Dr. Massey held several positions at Bristol-Myers Squibb Company where she led the neuroscience and infectious diseases medical teams.
Jill earned her Doctor of Pharmacy degree from the University of Nebraska Medical Center and her MBA from Drexel University. She completed her residency at Mercer University School of Pharmacy and Emory University in Atlanta, Georgia. She joined the faculty of the Saint Louis College of Pharmacy and served as the Director of Geriatric Pharmacy Practice at the Program on Aging at Washington University School of Medicine while maintaining a clinical practice at the Jewish Hospital of St. Louis until she started her pharmaceutical industry career.

My Speakers Sessions

Wednesday, April 15

1:45pm EDT